![]() |
Volumn 9, Issue 4, 2013, Pages 200-205
|
Determining target engagement in living systems
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BORTEZOMIB;
CARFILZOMIB;
DOPAMINE RECEPTOR BLOCKING AGENT;
DRUG;
HISTONE DEACETYLASE;
IBRUTINIB;
METHYLTRANSFERASE;
PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1;
PHOSPHOTRANSFERASE;
PHOSPHOTRANSFERASE INHIBITOR;
PROTEIN;
PROTEINASE;
RADIOLIGAND;
VORINOSTAT;
AUTOPHOSPHORYLATION;
BIOLOGICAL ACTIVITY;
CELLS;
DRUG DETERMINATION;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MECHANISM;
DRUG SCREENING;
DRUG SELECTIVITY;
DRUG TARGETING;
ENZYME ACTIVITY;
ENZYME ANALYSIS;
ENZYME INHIBITION;
GENE MUTATION;
HUMAN;
IN VIVO STUDY;
NONHUMAN;
NOTE;
PERIPHERAL BLOOD MONONUCLEAR CELL;
POLYACRYLAMIDE GEL ELECTROPHORESIS;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
PROTEOMICS;
TECHNOLOGY;
ANIMALS;
BIOMARKERS, PHARMACOLOGICAL;
CELL CULTURE TECHNIQUES;
CHROMATOGRAPHY, LIQUID;
DRUG EVALUATION, PRECLINICAL;
HUMANS;
IMMUNOPRECIPITATION;
MOLECULAR PROBES;
MOLECULAR TARGETED THERAPY;
PROTEIN ARRAY ANALYSIS;
RADIOPHARMACEUTICALS;
TANDEM MASS SPECTROMETRY;
VALIDATION STUDIES AS TOPIC;
|
EID: 84875428718
PISSN: 15524450
EISSN: 15524469
Source Type: Journal
DOI: 10.1038/nchembio.1211 Document Type: Note |
Times cited : (201)
|
References (57)
|